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health problems in infants and children, including 
more frequent and severe asthma attacks, respiratory 
infections, ear infections and sudden infant death 
syndrome. Vaping products, on the other hand, do not 
result in combustion that results in nicotine delivery 
and as a result do not generate harmful chemicals to 
the level of conventional cigarettes.
Scientific Summary
There is significant scientific evidence that suggests that 
vaping products seem to be a reduced harm alternative 
to combustible cigarettes.
 Â In its independent evidentiary review, Public 
Health England (PHE) has categorically concluded 
that “Vaping poses only a small fraction of the risks 
of smoking and switching completely from smoking 
to vaping conveys substantial health benefits over 
continued smoking. The previous estimate that, based on 
current knowledge, vaping is at least 95% less harmful 
than smoking remains a good way to communicate the 
large difference in relative risk unambiguously so that 
more smokers are encouraged to make the switch from 
smoking to vaping.” It has further observed that “To 
date, the levels of metals identified in e-cigarette aerosol 
do not give rise to any significant safety concerns, but 
metal emissions, however small, are unnecessary.” 
On assessment of exposure to harmful constituents, 
PHE has observed that “biomarkers of exposure assessed 
to date are consistent with significant reductions in 
harmful constituents and for a few biomarkers assessed...
similar levels to smokers abstaining from smoking or 
nonsmokers were observed.”
 Â The Royal College of Physicians has also opined 
that “Toxin levels inhaled from vaping products under 
It is a well-known fact that tobacco products, primarily combustible cigarettes, are the single greatest cause of tobacco-related diseases and kill 
about 7 million people worldwide each year. The 
tobacco epidemic in India has also reached alarming 
levels. As per the latest estimates, there are nearly 
106 million people in India who smoke tobacco and 
32 million who smoke as well as chew tobacco. There 
are ~270 million people who use tobacco in India. 
India is home to roughly 11.2% of the smokers in the 
world and 1.35 million people in the country die every 
year due to tobacco-related illnesses.
The indirect and direct costs of tobacco-related 
illnesses and deaths in India are also staggering. 
As per a Report by the Ministry of Health and Family 
Welfare, Government of India, the total economic costs 
attributable to tobacco usage related diseases in India, 
in the year 2011 for people aged between 35-69, was 
Rs. 1,04,500 crores (around US $22.4 billion). In recent 
times, many smokers have transitioned to vaping 
products in their efforts to quit combustible smoking 
or reduce harm created by the same. Vaping products 
contain heated nicotine extracted from tobacco, as well 
as a variety of flavorings and other additives.
It is important to note here that vaping is not the 
same as smoking as there is no combustion that is 
taking place. Combustion from smoking generates 
significant level of tar, carbon monoxide and other 
chemicals out of which 69 are known carcinogens. 
Combustible cigarettes accelerate cancer caused by 
the released chemicals. Second-hand smoking or 
passive smoking from combustion not only increases 
the risk of coronary heart disease by 25-40% (almost 
the same level as a smoker), but also causes numerous 
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normal conditions are likely to be well below prescribed 
threshold limit for occupational exposure, which make 
the probability of significant long-term harm unlikely.”
 Â The National Academies of Sciences, Engineering 
and Medicine (NASEM) has concluded in 
relevant part that “there is conclusive evidence that 
completely substituting e-cigarettes for combustible 
tobacco cigarettes reduces users’ exposure to numerous 
toxicant and carcinogens present in combustible tobacco 
cigarettes” and there is substantial evidence that 
completely switching from regular use of combustible 
tobacco products to vaping results in reduced short-term 
adverse health outcomes in several organ systems.” 
  As such, NASEM has concluded that “e-cigarettes 
pose less risk to an individual than combustible tobacco 
cigarettes” and “complete switching from combustible 
tobacco cigarettes to e-cigarettes would be expected to 
reduce tobacco-related health risk.” Lead authors of the 
NASEM report on vaping, Dr Eaton and St Helen, 
also published a follow-on Evidence to Practice 
article, which recommended that, “if a smoker’s 
initial treatment has failed or not been tolerated, or if 
the smoker refuses to use approved medications and 
counseling and wishes to use e-cigarettes to aid quitting, 
physician should encourage the smoker to switch 
completely to e-cigarettes. We agree with PHE that 
behavioral support should be provided to smokers who 
want to use e-cigarettes to help them quit smoking, and 
that health professionals should receive education and 
training in use of e-cigarettes in quit attempts.”
 Â The American Cancer Society has issued a 
statement that stipulates basis the available scientific 
evidence that the use of vaping is less harmful 
than smoking cigarettes. It has further observed 
that despite clinical advice, many smokers “…will 
not attempt to quit smoking cigarettes and will not use 
FDA approved cessation medications. These individuals 
should be encouraged to switch to the least harmful form 
of tobacco product possible; switching to the exclusive 
use of e-cigarettes is preferable to continuing to smoke 
combustible products.”
 Â The American Heart Association has observed that 
“E-cigarettes either do not contain or have lower levels of 
several tobacco-derived harmful and potentially harmful 
constituents compared with cigarettes and smokeless 
tobacco. In comparison with nicotine replacement 
therapies (NRTs), e-cigarette use has increased at an 
unprecedented rate, which presents an opportunity for 
harm reduction if smokers use them as substitutes for 
cigarettes.”
 Â David B Abrams from the College of Global 
Public Health, New York University, writes in 
the April 2018 issue of Annual Review of Public 
Health: “A diverse class of alternative nicotine delivery 
systems (ANDS) has recently been developed that do 
not combust tobacco and are substantially less harmful 
than cigarettes. ANDS have the potential to disrupt the 
120-year dominance of the cigarette and challenge the 
field on how the tobacco pandemic could be reversed if 
nicotine is decoupled from lethal inhaled smoke. ANDS 
may provide a means to compete with, and even replace, 
combusted cigarette use, saves more lives more rapidly 
than previously possible.”
Based on currently available evidence, using current 
generation vaping products is less harmful than smoking 
cigarettes, but the health effects of long-term use are 
not known. The Heart Care Foundation of India (HCFI) 
and undersigned medical practitioners recognize their 
responsibility to continue monitoring and evaluation 
of emerging scientific evidence in relation to vaping 
products and will always strive to promptly inform 
policy makers, public and medical practitioners of these 
findings.
clinical recommendationS
The undersigned medical practitioners and HCFI 
have always supported smokers in their efforts to quit 
smoking regardless of the approach giving paramount 
importance to their health and well-being. To help 
smokers quit, HCFI and the undersigned medical 
practitioners recommend clinicians to advise their 
patients to use available smoking cessation products 
coupled with behavioral counseling. 
However, we also note that many smokers are 
increasingly using vaping products to quit smoking 
or reduce the harm caused by combustible smoking. 
To this end, we recommend that the best option is to 
quit smoking altogether but if a smoker finds it tough, 
they should use vaping products. It is important 
to note here that all individuals/patients should be 
consistently advised to quit using any form of tobacco 
products or related products completely. We further 
caution against the concurrent use of vaping products 
and combustible cigarettes.
Policy recommendationS
The undersigned medical practitioners and HCFI would 
encourage the Government of India to frame policies 
and regulations of vaping products that addresses:
 Â Marketing and Advertisement
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 Â Youth access: Such products should only be 
available to smokers above the age of 21
 Â Safeguarding pregnant women from initiation and 
use through awareness campaigns
 Â Labeling
 Â Quality control over manufacturing
 Â Standards for contaminants.
Further, such regulations should allow adults to access 
quality-controlled products in their efforts to stop 
the use of combustible smoking with the objective to 
reduce harm.
It is also recommended that the Government of India 
should allocate funds for independent and continued 
research on the health effects of vaping products 
and guide their policies from time to time basis such 
evidence. There should be consistent guidance from 
regulatory authorities on product and ingredient 
standards with a view to further reduce toxicity and 
addictiveness of any tobacco product and related harm 
reduction products. Importantly, with respect to vaping 
products, manufacturers should be disallowed from 
making any unproven health claims unless the same has 
been approved by a relevant authority of the Ministry 
of Health and Family Welfare, Government of India. 
It is our strongest recommendation to refrain from 
initiation of consumption of any tobacco product and 
related harm reduction product. However, transitioning 
to a related harm reduction product presents an 
important and critical public health opportunity for 
existing smokers and must be encouraged through 
appropriate regulations and support from clinicians.
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